Dietary whey protein lessens several risk factors for metabolic diseases: a review
Data
2012-06-07
Autores
Sousa, Gabriela T. D.
Lira, Fabio Santos de
Rosa, Jose C.
Oliveira, Erick P. de
Oyama, Lila Missae [UNIFESP]
Santos, Ronaldo Vagner Thomatieli dos [UNIFESP]
Pimentel, Gustavo Duarte
Orientadores
Tipo
Resenha
Título da Revista
ISSN da Revista
Título de Volume
Resumo
Obesity and type 2 diabetes mellitus (DM) have grown in prevalence around the world, and recently, related diseases have been considered epidemic. Given the high cost of treatment of obesity/DM-associated diseases, strategies such as dietary manipulation have been widely studied; among them, the whey protein diet has reached popularity because it has been suggested as a strategy for the prevention and treatment of obesity and DM in both humans and animals. Among its main actions, the following activities stand out: reduction of serum glucose in healthy individuals, impaired glucose tolerance in DM and obese patients; reduction in body weight; maintenance of muscle mass; increases in the release of anorectic hormones such as cholecystokinin, leptin, and glucagon like-peptide 1 (GLP-1); and a decrease in the orexigenic hormone ghrelin. Furthermore, studies have shown that whey protein can also lead to reductions in blood pressure, inflammation, and oxidative stress.
Descrição
Citação
Lipids in Health and Disease. London: Biomed Central Ltd, v. 11, 9 p., 2012.